PCF Blog
Editorial deep-dives on peptide therapy, GLP-1 providers, semaglutide costs, hormone optimisation, and longevity clinics — written to help you compare care carefully. Informational only, not medical advice.
GLP-1August 15, 2026
You've been taking a GLP-1 medication for eight months. The weight is down. The bloodwork looks better. But your physician just forwarded you a paper from…
Read article
GLP-1August 10, 2026
A 52-year-old cardiologist sits across from her endocrinologist with lab results showing elevated fasting insulin, a creeping HOMA-IR score, and visceral…
Read article
GLP-1August 1, 2026
You've done the research on both major GLP-1 options, you know one targets a single receptor and the other hits two, and you're trying to figure out…
Read article
GLP-1July 31, 2026
Your fasting glucose reads 108 mg/dL. Your doctor says you're not diabetic. You leave the appointment relieved — but that number sits in a range the…
Read article
GLP-1July 24, 2026
You started a GLP-1 medication to lose weight. Six months in, you've dropped 14% of your body weight — roughly in line with what the SURMOUNT-1 trial…
Read article
GLP-1July 23, 2026
You're at a women's health clinic because your thirties have left you carrying 22 extra pounds that didn't respond to the usual interventions, and your GP…
Read article
GLP-1July 11, 2026
You've been on a GLP-1 medication for eight months, lost 18 pounds, and now your insurance has dropped coverage, the compounding pharmacy you relied on…
Read article
GLP-1July 10, 2026
You've been on a GLP-1 medication for eight months, lost 18 pounds, and now your prescription is running $400 a month out of pocket. Your prescriber…
Read article
GLP-1June 30, 2026
You've been on a GLP-1 receptor agonist for six months, lost a meaningful amount of weight, and your prescriber is now asking whether you want to switch…
Read article
GLP-1June 29, 2026
You've been quoted $1,200 a month for a GLP-1 medication program, your insurance denied the claim, and the compounding pharmacy your friend used just got…
Read article
GLP-1June 21, 2026
You've been approved for a GLP-1 prescription and your clinic is offering you a choice. Semaglutide at roughly $200–$250/month through a telehealth…
Read article
GLP-1June 19, 2026
You're not trying to lose 80 pounds. You're trying to slow down the clock — the arterial stiffness creeping up on your blood pressure readings, the…
Read article
GLP-1June 8, 2026
You've narrowed it down to three or four telehealth platforms, you have tabs open, and every landing page says roughly the same thing: affordable,…
Read article
GLP-1June 3, 2026
You've done two or three hours of research, you have five browser tabs open comparing telehealth platforms, and you still can't tell whether you're about…
Read article
GLP-1May 29, 2026
You're six weeks into semaglutide at 0.5 mg weekly and the nausea is bad enough to consider quitting. Your prescriber says titrate up anyway. But a…
Read article
GLP-1May 27, 2026
You've done the research, you know what semaglutide does, and you're ready to start. Now you're staring at a dozen telehealth platforms all claiming to…
Read article
GLP-1May 19, 2026
You're not trying to lose 50 pounds. You're 15 pounds over where you feel best, your appetite has been running hotter than usual, and you've watched a…
Read article
GLP-1May 16, 2026
You've been eating well and exercising three times a week for eight months. The scale has moved exactly four pounds. Your doctor says your A1C is 5.3 —…
Read article
GLP-1May 12, 2026
The rise of GLP-1 medications like semaglutide has fundamentally changed how many people approach weight management and metabolic health. Yet not everyone…
Read article
GLP-1May 5, 2026
As millions of people worldwide use GLP-1 receptor agonists for weight management and blood sugar control, questions about long-term safety have moved…
Read article
GLP-1May 3, 2026
As we move into 2026, semaglutide has evolved far beyond its original diabetes and weight management applications. What started as a pharmaceutical…
Read article
GLP-1May 3, 2026
The rise of medications like semaglutide has sparked widespread interest in weight management, but not everyone wants to pursue pharmaceutical options—or…
Read article
GLP-1May 2, 2026
While GLP-1 receptor agonists gained widespread attention as weight loss medications, a quieter conversation has emerged among researchers and clinicians…
Read article
GLP-1May 2, 2026
Two medications have dominated headlines in weight management and metabolic health discussions: tirzepatide and semaglutide. Both represent advances in…
Read article
GLP-1May 1, 2026
When GLP-1 receptor agonists first entered public consciousness, the conversation centered almost entirely on weight reduction. But emerging research and…
Read article